Subtitles are available in English and other languages. They are automatically generated using AI, so some errors may occur.

Major Late-Breaking Trials from EuroPCR 2025

Other coronary interventions
Other valvular and structural interventions
Hotline / Late-Breaking Trials
Theatre Bleu

Anchorperson: Bernard Prendergast

Spokesperson: Thomas Cuisset

Discussants: Davide Capodanno, David Moliterno, Gilles Montalescot, Stephan Windecker

Introduction

Bernard Prendergast

Tribute to Jean-Philippe Collet
Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies

Rajesh Kharbanda

Study insights

Davide Capodanno

Discussion and audience interaction
Clinical impact

Davide Capodanno

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Flavio Luciano Ribichini

Study insights

Stephan Windecker

Discussion and audience interaction
Clinical impact

Stephan Windecker

One-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in Acute Coronary Syndrome

Woong Chol Kang

Study insights

Gilles Montalescot

Discussion and audience interaction
Clinical impact

Gilles Montalescot

Conclusion

Thomas Cuisset

Suggested videos